A primer on cancer immunology and immunotherapyLOTZE, Michael T; PAPAMICHAIL, Michael.Cancer immunology and immunotherapy. 2004, Vol 53, Num 3, pp 135-138, issn 0340-7004, 4 p.Article

Therapeutic cancer vaccines: a long and winding road to successBAXEVANIS, Constantin N; PAPAMICHAIL, Michael; PEREZ, Sonia A et al.Expert review of vaccines. 2014, Vol 13, Num 1, pp 131-144, issn 1476-0584, 14 p.Article

Characterization of a novel cell penetrating peptide derived from Bag-1 proteinNIARCHOS, Dimitrios K; PEREZ, Sonia A; PAPAMICHAIL, Michael et al.Peptides (New York, NY. 1980). 2006, Vol 27, Num 11, pp 2661-2669, issn 0196-9781, 9 p.Article

Increased frequency of CD4⁺ cells expressing CD161 in cancer patientsILIOPOULOU, Eleni G; KARAMOUZIS, Michalis V; MISSITZIS, Ioannis et al.Clinical cancer research. 2006, Vol 12, Num 23, pp 6901-6909, issn 1078-0432, 9 p.Article

Quantitative fluorescence cytometric measurement of estrogen and progesterone receptors: correlation with the hormone binding assayGRITZAPIS, Angelos D; BAXEVANIS, Constantin N; MISSITZIS, Ioannis et al.Breast cancer research and treatment. 2003, Vol 80, Num 1, pp 1-13, issn 0167-6806, 13 p.Article

HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4⁺T cell clonesPEREZ, Sonia A; SOTIROPOULOU, Panagiota A; SOTIRIADOU, Nectaria N et al.Cancer immunology and immunotherapy. 2002, Vol 50, Num 11, pp 615-624, issn 0340-7004Article

Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapyBAXEVANIS, Constantin N; SOTIROPOULOU, Panagiota A; SOTIRIADOU, Nectaria N et al.Cancer immunology and immunotherapy. 2004, Vol 53, Num 3, pp 166-175, issn 0340-7004, 10 p.Conference Paper

Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA)TSITSILONIS, Ourania E; THRASYVOULIDES, Apollon; BALAFAS, Apostolos et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 4, pp 811-822, issn 0731-7085, 12 p.Article

In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu- specific antibody and the γ-chain from Fc(ε) RIMAMALAKI, Avgi; GRITZAPIS, Angelos D; KRETSOVALI, Androniki et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 8, pp 513-522, issn 0340-7004, 10 p.Article

Natural CD8⁺ T-cell responses against MHC class I epitopes of the HER-2/neu oncoprotein in patients with epithelial tumorsSOTIROPOULOU, Panagiota A; PEREZ, Sonia A; VOELTER, Volfgang et al.Cancer immunology and immunotherapy. 2003, Vol 52, Num 12, pp 771-779, issn 0340-7004, 9 p.Article

Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapyLEKKA, Eftychia; GRITZAPIS, Angelos D; PEREZ, Sonia A et al.Cancer immunology and immunotherapy. 2010, Vol 59, Num 5, pp 715-727, issn 0340-7004, 13 p.Article

Results from a Phase I Clinical Study of the Novel Li-Key/HER-2/neu(776-790) Hybrid Peptide Vaccine in Patients with Prostate CancerPEREZ, Sonia A; KATLLINTERIS, Nikoletta L; BISIAS, Stratos et al.Clinical cancer research (Print). 2010, Vol 16, Num 13, pp 3495-3506, issn 1078-0432, 12 p.Article

CD4⁺CD25⁺ regulatory T-cell frequency in HER-2/neu (HER)-positive and her-negative advanced-stage breast cancer patientsPEREZ, Sonia A; KARAMOUZIS, Michael V; PAPAMICHAIL, Michael et al.Clinical cancer research. 2007, Vol 13, Num 9, pp 2714-2721, issn 1078-0432, 8 p.Article

Efficacy of novel culture environments on the ex vivo expansion kinetics of cord blood progenitor cellsCACOULIOS, Nike T; GRITZAPIS, Angelos D; TSITSILONIS, Athanasios E et al.Haematologica (Roma). 2002, Vol 87, Num 3, pp 320-321, issn 0390-6078Article

HER-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3⁺CD56⁺ (natural killer T) lymphocytesBAXEVANIS, Constantin N; GRITZAPIS, Angelos D; TSITSILONIS, Ourania E et al.International journal of cancer. 2002, Vol 98, Num 6, pp 864-872, issn 0020-7136Article

HER-2/neu (657-665) represents an immunogenic epitope of HER-2/neu oncoprotein with potent antitumor propertiesGRITZAPIS, Angelos D; FRIDMAN, Arthur; PEREZ, Sonia A et al.Vaccine. 2010, Vol 28, Num 1, pp 162-170, issn 0264-410X, 9 p.Article

Peptide Vaccination Breaks Tolerance to HER-2/neu by Generating Vaccine-Specific FasL⁺ CD4⁺ T Cells: First Evidence for Intratumor Apoptotic Regulatory T CellsGRITZAPIS, Angelos D; VOUTSAS, Loannis F; LEKKA, Eftychia et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 7, pp 2686-2696, issn 0008-5472, 11 p.Article

A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survivalPEREZ, Sonia A; MAHAIRA, Louisa G; DEMIRTZOGLOU, Fillio J et al.Blood. 2005, Vol 106, Num 1, pp 158-166, issn 0006-4971, 9 p.Article

A novel myeloid-like NK cell progenitor in human umbilical cord bloodPEREZ, Sonia A; SOTIROPOULOU, Panagiota A; GKIKA, Dimitra G et al.Blood. 2003, Vol 101, Num 9, pp 3444-3450, issn 0006-4971, 7 p.Article

A skeletal muscle troponin T specific ELISA based on the use of an antibody against the soluble troponin T (16-31) fragmentTSITSILONIS, Ourania E; STOEVA, Stanka; ECHNER, Hartmut et al.Journal of immunological methods. 2002, Vol 268, Num 2, pp 141-148, issn 0022-1759, 8 p.Article